Who is Specialist Neuropsychologist Dr. Alptekin Aydın
BA (Hons) – MSc – GMBPsS – PhD (DClinPsy)
Specialist Neuropsychologist & (CUBS) Expert Witness for Civil Law
Certified TMS Practitioner – QEEG & Advanced EEG Interpretation Certificate
Dr. Alptekin Aydın: A Pioneer in Neuromodulation and Cognitive Neuroscience
Dr. Alptekin Aydın, a Specialist Neuropsychologist and Certified TMS Practitioner, was born in 1973 in Moda, Istanbul. After graduating with First-Class Honours (1st) from the Department of Psychology at Istanbul University, he completed his internship in Psychology and Philosophy Teaching Formation at Galatasaray High School. His early research focused on identifying, diagnosing, and treating autism, learning difficulties, and ADHD in children, with a particular emphasis on school adaptation challenges.
Dr. Aydın pursued a Master’s degree in Psychology at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London, specializing in Neurological and Pharmacological Substance Addiction. His academic journey continued with a Doctorate (DClinPsy) in Clinical Psychology and Neuroscience in the United States, where he published groundbreaking research titled:
“Assessing the Impact of tDCS Treatment Over the Dorsolateral Prefrontal Cortex (DLPFC) on Social Communication in Children with ASD: A Survey of Family Experiences.”
Dr. Aydın further specialized in neuromodulation by completing the International Clinical TMS Certification program at Maastricht University (UM) in the Netherlands, obtaining accreditation from the European Accreditation Council for Continuing Medical Education (EACCME) as a Certified Transcranial Magnetic Stimulation (TMS) and tDCS practitioner.
Contributions to Neuroscience, Research, and Public Health Initiatives
In June 2014, Dr. Aydın participated in the Greenwich Beresford Project, a collaborative research effort between the UK Department of Health and King’s College University. In 2015, he extended his expertise to individuals struggling with Gambling Addiction, providing Cognitive Behavioral Therapy through Redcard Gambling. His work expanded to include municipal-level healthcare initiatives, supporting councils such as Haringey, Hackney, and Enfield in developing neuromodulation-based treatment programs for mental health and addiction recovery.
In addition to his contributions to neuromodulation, he received training in Mora Bioresonance (Quantum Frequency Technology) therapy for smoking, alcohol, and substance addiction. As a Certified Bioresonance Practitioner, he has treated over 3,000 adults for substance addiction, integrating his proprietary Neuromodulation TMS, Quantum Frequency Therapy, and Cognitive Behavioral Therapy (CBT) protocols.
A Revolution in Personalized Neuromodulation Therapy
In 2018, Dr. Aydın developed and introduced a groundbreaking scientific method known as QPAN (QEEG-Guided Personalized AI-Based Neuromodulation Therapy). This system, utilizing TMS and tDCS for individuals with special needs, was specifically designed for those with: Autism Spectrum Disorder (ASD) Learning Difficulties (Dyslexia, Dyscalculia, Dysgraphia) Epilepsy and Epileptic Wave Regulation Attention Deficit and Hyperactivity Disorder (ADHD) QPAN was the first AI-integrated neuromodulation system worldwide, pioneering a comprehensive therapeutic approach that merges QEEG brain scan technology, AI-driven brain function mapping, and personalized neuromodulation treatment protocols. This multi-disciplinary system integrates: Therapeutic Brain Stimulation (TMS, tDCS, tACS, and Neurofeedback) Cognitive Training & Educational Programs Tailored Sports and Motor Activity Interventions Personalized Nutrition and Metabolic Optimization Since its development, QPAN has successfully been applied to over 5,000 individuals, demonstrating an impressive success rate of 70-85% in improving cognitive function, emotional regulation, and adaptive learning skills.
Why Us?
A Legacy of Innovation and Dedication to Brain Health
Dr. Alptekin Aydın’s contributions to neuromodulation, cognitive neuroscience, and mental health treatment have positioned him as a leader in the field of personalized neurostimulation therapies. His research, clinical expertise, and pioneering development of QPAN AI-driven neuromodulation continue to reshape the future of neurological and psychiatric treatment world. Continuous follow-ups with a dedicated call centre, Cosmos Istanbul PLC plays a crucial role in making home-based brain stimulation treatments more effective, accessible, and user-friendly.
The largest Neuromodulation TMS and tDCS clinic in Enfield, England.
Autism, ADHD, and Learning Difficulties Epilepsy and Neurological Pain Management Depression, Anxiety, and OCD Stroke Rehabilitation and Post-Injury Neuroplasticity Enhancement Substance Addiction and Behavioral Health Recovery In addition to his leadership at Cosmos Healthcare Ltd., Dr. Alptekin Aydın serves as Chairman of the Board at Cosmos Istanbul PLC, an organization dedicated to supporting remote tDCS treatment users worldwide.
Cosmos Healthcare is home to a multidisciplinary team of specialists:
HCPC-Registered Occupational Therapists (Adult & Children) Certified TMS and tDCS Practitioners Specialist Psychologists and Addiction Experts QEEG Reporting and Neurofeedback Specialists Consultant Speech and Language Therapists (SLT) Each expert within the Cosmos Healthcare team is committed to delivering world-class, patient-centered care, ensuring that individuals receive not only cutting-edge treatment but also compassionate and effective rehabilitation services.
Pioneering Personalized Neuroscience and Holistic Healthcare
Cosmos Healthcare stands for the conviction that all people should receive personalized treatment plans for neurological and psychological care based on scientific evidence. We provide advanced neuroscience-based treatments and cognitive enhancement programs together with rehabilitation methods which are informed by current research in neuromodulation neurofeedback and advanced brain mapping techniques.
Our internationally renowned team collaborates with multidisciplinary experts to develop comprehensive treatment plans based on scientific research that are customized for each individual’s distinct neurological characteristics. Service users participate in a data-oriented precision-based rehabilitation process designed for enduring success rather than merely receiving care.
Our Approach: Where Science Meets Personalized Care
Our methodology centers around combining QEEG functional brain mapping with AI-powered Neuromap analysis alongside neuromodulation therapy and evidence-based neurocognitive rehabilitation techniques.